🧬 ICD-10 CM E21.0 — Primary Hyperparathyroidism
Billable Code Confirmed
ICD-10 CM E21.0 is a complete, fully specified 4-character ICD-10-CM code with no further subdivision required, making it valid for billing in all care settings.¹ It specifically identifies hyperparathyroidism arising from an intrinsic parathyroid gland abnormality (adenoma or hyperplasia) rather than a secondary or unspecified cause.
Non-Billable Parent Codes
E21 (Hyperparathyroidism and other disorders of parathyroid gland) is a non-billable category header; it lacks the fourth character needed to specify whether the hyperparathyroidism is primary, secondary, other, or unspecified, and cannot be submitted on a claim.
Clinical Context
Selection of E21.0 over its siblings depends on documented laboratory confirmation of an intrinsic parathyroid source — elevated parathyroid hormone (PTH) with concurrent hypercalcemia not attributable to renal disease, vitamin D deficiency, or another secondary cause.
Code Classification
ICD-10 CM E21.0 is a diagnosis code used to report an endocrine metabolic condition; it is not a procedure code and must be paired with the appropriate CPT/HCPCS code when a related service (lab test, imaging, or surgery) is billed.
🔍 Code Description
ICD-10 CM E21.0 designates primary hyperparathyroidism, a condition in which one or more parathyroid glands autonomously overproduce parathyroid hormone (PTH), most commonly due to a solitary parathyroid adenoma, and less frequently due to multi-gland hyperplasia or, rarely, parathyroid carcinoma. The excess PTH drives increased bone resorption, enhanced renal calcium reabsorption, and elevated intestinal calcium absorption via activated vitamin D, producing the hallmark laboratory picture of concurrent hypercalcemia and inappropriately elevated or normal PTH. Clinically, this differs from E21.1 (secondary hyperparathyroidism), where the parathyroid gland responds appropriately to an external stimulus such as chronic kidney disease or vitamin D deficiency, and low serum calcium (not high) typically drives the elevated PTH.
Diagnosis of E21.0 typically follows an incidental finding of hypercalcemia on routine labs, prompting confirmatory PTH testing and localization imaging such as a sestamibi scan or neck ultrasound. When laboratory and clinical findings do not clearly establish primary versus another parathyroid disorder, coders should default to E21.3 (hyperparathyroidism, unspecified) rather than E21.0, since inappropriately assigning the “primary” code without documented etiology confirmation is a common audit target. Management ranges from surveillance for mild, asymptomatic cases to parathyroidectomy for symptomatic disease or patients meeting surgical criteria (marked hypercalcemia, nephrolithiasis, osteoporosis, or age under 50).
🌳 Code Tree / Hierarchy
E21 Hyperparathyroidism and other disorders of parathyroid gland ❌ Non-billable
│
├── E21.0 Primary hyperparathyroidism ◀ THIS CODE ✅ Billable
├── E21.1 Secondary hyperparathyroidism, not elsewhere classified ✅ Billable
│
├── E21.2 Other hyperparathyroidism ✅ Billable
│
├── E21.3 Hyperparathyroidism, unspecified ✅ Billable
│
├── E21.4 Other specified disorders of parathyroid gland ✅ Billable
│
└── E21.5 Disorder of parathyroid gland, unspecified ✅ BillableSpecificity Matters for Surgical Coverage
Selecting E21.0 rather than the unspecified E21.3 can be pivotal for prior authorization of parathyroidectomy, since many payer medical policies require documented confirmation of a primary (not secondary or renal-related) etiology before approving surgery.
Tip
Always verify that both an elevated calcium level and an elevated or inappropriately normal PTH are documented together before assigning E21.0; a single abnormal lab value alone does not support this diagnosis.
✅ Includes
- Primary hyperparathyroidism due to a solitary parathyroid adenoma, the most common etiology, accounting for roughly 80-85% of cases.
- Primary hyperparathyroidism due to multi-gland parathyroid hyperplasia.
- Hypercalcemia clearly attributed to an intrinsic, autonomously functioning parathyroid gland.
- Asymptomatic primary hyperparathyroidism identified incidentally through routine calcium screening.
❌ Excludes
Excludes 1
M83 — Adult osteomalacia is a distinct bone mineralization disorder related to vitamin D or phosphate metabolism, not to autonomous parathyroid hormone overproduction, and must not be coded with E21.0 for the same condition. E34.2 — Ectopic hormone secretion (ectopic hyperparathyroidism, e.g., PTH-related peptide from a non-parathyroid tumor) represents a fundamentally different mechanism than intrinsic gland overactivity and is mutually exclusive with E21.0. E83.81 — Hungry bone syndrome is a postoperative metabolic complication following parathyroidectomy, not the primary hyperparathyroid state itself, and should be coded separately rather than in place of E21.0.
Danger
The most common Excludes1 error is reporting E21.0 alongside E83.81 in the immediate postoperative period when the patient has developed hungry bone syndrome — once parathyroidectomy has resolved the primary disease, E21.0 should be replaced by the postoperative complication code rather than co-reported.
Excludes 2
E83.52 — Familial hypocalciuric hypercalcemia is a genetically distinct, non-surgical cause of hypercalcemia that can be documented alongside E21.0 only when both a true parathyroid adenoma/hyperplasia and a separately confirmed genetic hypocalciuric hypercalcemia disorder coexist, which is clinically uncommon but codeable when both are independently substantiated.
📋 Clinical Overview
Primary vs. Secondary vs. Unspecified Hyperparathyroidism
Distinguishing primary from secondary hyperparathyroidism hinges on whether the calcium level is high or low at the time of PTH elevation, since this single lab pairing determines the underlying pathophysiology and treatment pathway. Primary disease reflects autonomous gland dysfunction, secondary disease reflects an appropriate compensatory response to a separate metabolic derangement, and the unspecified code should be reserved for cases where documentation does not clarify the mechanism.
| Feature | E21.0 | E21.1 | E21.3 |
|---|---|---|---|
| Calcium level | Typically elevated, reflecting autonomous PTH secretion independent of physiologic feedback. | Typically low or low-normal, since the parathyroid is responding appropriately to hypocalcemia from another cause such as CKD or vitamin D deficiency. | Not clearly documented; calcium status may be pending or inconsistently recorded, preventing classification as primary or secondary. |
| Common etiology | Solitary parathyroid adenoma, multi-gland hyperplasia, or rarely parathyroid carcinoma. | Chronic kidney disease, vitamin D deficiency, malabsorption, or chronic phosphate binder use driving compensatory PTH rise. | Unclear or undocumented etiology; often used as a placeholder pending further workup. |
| Treatment direction | Surgical parathyroidectomy is curative for symptomatic or criteria-meeting cases; asymptomatic mild cases may be monitored. | Management targets the underlying cause (e.g., vitamin D repletion, CKD-mineral bone disease therapy) rather than direct parathyroid surgery. | Requires further diagnostic clarification before a definitive treatment plan or coding refinement can be applied. |
Important
A CDI trigger should fire whenever “hyperparathyroidism” appears in documentation without a clearly stated calcium value or explicit primary/secondary distinction, since this directly affects whether E21.0, E21.1, or E21.3 is the compliant code choice.
Manifestations & Symptom Burden
- Nephrolithiasis (kidney stones) from chronic hypercalciuria, one of the classic surgical indications for parathyroidectomy.
- Osteoporosis or reduced bone mineral density from chronic PTH-driven bone resorption, often documented via DXA scan.
- Neuropsychiatric symptoms including fatigue, depression, and cognitive slowing (“moans, groans, stones, and bones” mnemonic).
- Gastrointestinal symptoms such as constipation, nausea, and peptic ulcer disease related to hypercalcemia.
- Cardiovascular effects including hypertension and, in severe hypercalcemic crisis, arrhythmia.
Tip
When these manifestations are documented as due to primary hyperparathyroidism, they should be coded as additional, separately reportable diagnoses (e.g., nephrolithiasis, osteoporosis) alongside E21.0 rather than assumed to be captured by the parathyroid code alone, since ICD-10-CM does not bundle manifestation codes into E21.0.
💰 HCC Risk Adjustment
| Model | HCC Mapping | Notes |
|---|---|---|
| CMS-HCC V24 | HCC 23 — Other Significant Endocrine and Metabolic Disorders | Confirmed active mapping; requires annual MEAT documentation for RAF capture. |
| CMS-HCC V28 | Comparable endocrine/metabolic HCC category | Verify against the current plan-year technical specifications, as V28 restructured several endocrine HCC groupings. |
ICD-10 CM E21.0 carries meaningful risk-adjustment value because it reflects an active, chronic endocrine disorder rather than a resolved lab abnormality.⁴ To capture the RAF weight, documentation each calendar year must show the condition is being actively monitored, evaluated, or treated (MEAT criteria) — for example, trending calcium/PTH levels, a referral for surgical evaluation, or documented decision for continued surveillance. Reporting E21.0 based solely on a remote history or an isolated abnormal lab value without a current assessment is a frequent RADV audit finding. Once a patient undergoes curative parathyroidectomy, continued use of E21.0 in subsequent years is generally inappropriate and should be replaced with a personal history code if applicable.
🏥 MS-DRG Assignment
| DRG | Title | CC/MCC Status |
|---|---|---|
| 643 | Endocrine Disorders with MCC | Requires a qualifying major complication/comorbidity as a secondary diagnosis. |
| 644 | Endocrine Disorders with CC | Requires a qualifying complication/comorbidity as a secondary diagnosis. |
| 645 | Endocrine Disorders without CC/MCC | Assigned when no qualifying CC/MCC is present. |
ICD-10 CM E21.0 groups to MDC 10 and the DRG 643-645 family when reported as the principal diagnosis for a medical (non-surgical) admission focused on hyperparathyroidism.⁵ Because E21.0 itself does not independently function as a CC or MCC, DRG weight is determined entirely by the presence of secondary diagnoses such as hypercalcemic crisis, acute kidney injury, or significant arrhythmia. If the admission’s primary focus is a parathyroidectomy, the procedure code will typically drive assignment to a surgical DRG rather than the medical 643-645 family. Coders should confirm that E21.0 accurately reflects the reason for admission before sequencing it as principal diagnosis, and should query providers for unspecified severity language (e.g., “elevated calcium”) that could otherwise understate the case’s true complexity.
🔗 Related ICD-10-CM Codes
Parathyroid Disorder Family
- E21.1 — Secondary hyperparathyroidism, not elsewhere classified
- E21.2 — Other hyperparathyroidism
- E21.3 — Hyperparathyroidism, unspecified
- E21.4 — Other specified disorders of parathyroid gland
- E21.5 — Disorder of parathyroid gland, unspecified
- E83.52 — Hypercalcemia
Associated Complications and Comorbidities
- N20.0 — Calculus of kidney
- M81.0 — Age-related osteoporosis without current pathological fracture
- R79.0 — Abnormal level of blood mineral (nonspecific hypercalcemia finding)
- K21.9 — Gastro-esophageal reflux disease without esophagitis (associated GI symptom workup)
- F32.9 — Major depressive disorder, single episode, unspecified (neuropsychiatric manifestation)
🛠️ Commonly Associated CPT Codes
- 60500 — Parathyroidectomy or exploration of parathyroid(s); this is the primary surgical treatment code for confirmed primary hyperparathyroidism and includes exploration of all four glands regardless of how many are ultimately removed.
- 60502 — Parathyroidectomy or exploration of parathyroid(s), re-exploration; used when a patient requires a second surgical exploration after a prior parathyroid procedure, such as for persistent or recurrent disease.
- 60505 — Parathyroidectomy or exploration of parathyroid(s), with mediastinal exploration, sternal split, or transthoracic approach; reported when an ectopic mediastinal parathyroid gland requires a more extensive surgical approach.
- 60512 — Parathyroid autotransplantation, an add-on code reported only in conjunction with a primary parathyroidectomy code when excised parathyroid tissue is reimplanted into forearm or neck muscle.
- 83970 — Parathyroid hormone (PTH) lab test, the key confirmatory laboratory study supporting the E21.0 diagnosis and subject to specific LCD frequency limitations.
- 78072 — Parathyroid planar imaging with tomographic (SPECT) localization, commonly performed preoperatively to localize an adenoma before parathyroidectomy.
NCCI Bundling Considerations
CPT 60500, 60502, and 60505 are frequently bundled with concurrent thyroidectomy codes under NCCI edits, so a bilateral thyroid and parathyroid procedure in the same session generally requires modifier -59 with clear documentation of medical necessity for separate reporting.⁶ The add-on code 60512 must never be billed as a stand-alone line item and requires a qualifying primary parathyroidectomy code on the same claim. PTH lab testing (83970) is subject to LCD frequency edits, so repeat testing beyond the allowed annual frequency for stable, non-operated hyperparathyroidism patients may be denied absent supporting clinical justification.
🔬 ICD-10-PCS Crosswalk
- 0GB00ZZ — Excision of Parathyroid Gland, Open Approach; used for inpatient reporting of a single-gland parathyroidectomy performed through an open cervical incision.
- 0GB03ZZ — Excision of Parathyroid Gland, Percutaneous Approach; applies when a minimally invasive percutaneous technique is used rather than an open neck exploration.
- 0GT00ZZ — Resection of Parathyroid Gland, Open Approach; reported when all parathyroid tissue is entirely removed (total parathyroidectomy) rather than a partial excision.
- 0GB04ZZ — Excision of Parathyroid Gland, Percutaneous Endoscopic Approach; used for minimally invasive endoscopic-assisted parathyroid surgery performed via small port incisions.
💊 Coding Scenarios and Examples
Scenario 1: A 62-year-old woman is referred for incidentally discovered hypercalcemia found on a routine metabolic panel. Follow-up labs confirm an elevated PTH level with concurrent elevated calcium, and a sestamibi scan identifies a single hyperfunctioning parathyroid adenoma. She is scheduled for outpatient parathyroidectomy.
- Correct coding: E21.0 (Primary hyperparathyroidism) as principal diagnosis; 60500 (Parathyroidectomy or exploration of parathyroid(s)) as the procedure code.
- Sequencing explanation: E21.0 is sequenced first because it is the definitive diagnosis driving the surgical intervention, with lab and imaging confirmation of an intrinsic gland source.
- CDI note: Ensure the operative report documents the number of glands explored and removed to support accurate procedure code selection and any applicable modifier.
Scenario 2: A 71-year-old man with stage 4 chronic kidney disease is found to have an elevated PTH with low-normal calcium on routine labs, consistent with a compensatory parathyroid response to his renal disease rather than autonomous overactivity.
- Correct coding: E21.1 (Secondary hyperparathyroidism, not elsewhere classified) as the reportable diagnosis, not E21.0, since the calcium pattern and clinical context indicate a secondary, renal-driven process.
- Sequencing explanation: The underlying CKD stage should also be coded and may be sequenced per documentation of the causal relationship, since secondary hyperparathyroidism in this context is a recognized CKD-related complication.
- CDI note: Query the nephrologist if documentation uses the generic term “hyperparathyroidism” without specifying the calcium pattern, since this directly affects whether E21.0 or E21.1 applies.
Scenario 3: A 55-year-old woman with confirmed primary hyperparathyroidism undergoes parathyroidectomy; two days postoperatively she develops severe hypocalcemia with elevated alkaline phosphatase consistent with hungry bone syndrome.
- Correct coding: E83.81 (Hungry bone syndrome) as the diagnosis for the postoperative complication; E21.0 should no longer be reported as the active condition once the causative gland has been surgically resected.
- Sequencing explanation: E83.81 is sequenced as it now represents the acute, actively managed condition; the resolved primary hyperparathyroidism is not concurrently coded per the Excludes1 relationship.
- CDI note: Documentation should clearly transition from “primary hyperparathyroidism” to the specific postoperative complication to avoid inappropriate continued use of E21.0 after curative surgery.
⚠️ Coding Pitfalls and Tips
- Do not assign E21.0 based solely on an elevated calcium level without a corresponding elevated or inappropriately normal PTH result documented in the record.
- Avoid defaulting to E21.0 when the etiology is unclear; use E21.3 instead until primary versus secondary status is confirmed by the treating provider.
- Remember that E21 alone is a non-billable parent code and will result in a claim rejection if submitted without a fourth character.
- Do not continue reporting E21.0 in years following a documented curative parathyroidectomy; verify whether a personal history code is more appropriate for risk-adjustment accuracy.
- When billing 60512 for parathyroid autotransplantation, confirm it is never submitted as a stand-alone line without an accompanying primary parathyroidectomy code such as 60500.
- Check LCD frequency limits before repeating 83970 PTH lab testing, since routine annual testing beyond documented medical necessity intervals may be denied.
Sources: ¹ ICD-10-CM 2026 Tabular List, Chapter 4 (E20-E35), National Center for Health Statistics/CMS. ² ICD10Data.com — E21.0 Primary hyperparathyroidism, 2026 code set. ³ CMS ICD-10-CM/PCS MS-DRG Definitions Manual, v44.0 — MDC 10 Endocrine Disorders (DRG 643-645). ⁴ CMS-HCC Risk Adjustment Model, Version 24 and Version 28 technical specifications, 2026 plan year. ⁵ AAPC — Parathyroidectomy CPT and ICD-10-CM coding guide, 2026. ⁶ Novitas Solutions/Palmetto GBA LCD — Parathormone (Parathyroid Hormone) Billing and Coding Article (A57122), effective 2026.